Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Dec 20;17(12):1725.
doi: 10.3390/ph17121725.

Natural Antimicrobial Peptides and Their Synthetic Analogues for Effective Oral Microflora Control and Oral Infection Treatment-The Role of Ceragenins in the Development of New Therapeutic Methods

Michał Czarnowski  1 , Urszula Wnorowska  1 , Milena Łuckiewicz  2 , Ewelina Dargiewicz  3 , Jakub Spałek  4 , Sławomir Okła  4 , Beata Sawczuk  5 , Paul B Savage  6 , Robert Bucki  1 , Ewelina Piktel  2
Affiliations
Review

Natural Antimicrobial Peptides and Their Synthetic Analogues for Effective Oral Microflora Control and Oral Infection Treatment-The Role of Ceragenins in the Development of New Therapeutic Methods

Michał Czarnowski et al. Pharmaceuticals (Basel). .

Abstract

Oral diseases, both acute and chronic, of infectious or non-infectious etiology, represent some of the most serious medical problems in dentistry. Data from the literature increasingly indicate that changes in the oral microbiome, and therefore, the overgrowing of pathological microflora, lead to a variety of oral-localized medical conditions such as caries, gingivitis, and periodontitis. In recent years, compelling research has been devoted to the use of natural antimicrobial peptides as therapeutic agents in the possible treatment of oral diseases. This review focuses on the potential of ceragenins (CSAs), which are lipid analogs of natural antimicrobial peptides, as molecules for the development of new methods for the prevention and treatment of oral diseases. Studies to date indicate that ceragenins, with their spectrum of multidirectional biological activities, including antimicrobial, tissue regeneration-stimulating, anti-inflammatory, and immunomodulatory properties, are strong candidates for further development of oral formulations. However, many of the beneficial properties of ceragenins require confirmation in experimental conditions reproducing the oral environment to fully determine their application potential. Their transition to practical use also requires more advanced testing of these molecules in clinical trials, which have only been conducted in limited numbers to date.

Keywords: antimicrobial peptides; ceragenins; oral cavity.

PubMed Disclaimer

Conflict of interest statement

P.B.S. and R.B. are the paid consultants of N8 Medical, which focuses on the commercialization of medical devices that incorporate ceragenins.

Figures

Figure 1
Figure 1
The biological activities of ceragenins. Details on the molecular mechanisms of reported effects are described in more detail below.
Figure 2
Figure 2
Potential applications of ceragenins in the treatment of oral diseases.
Figure 3
Figure 3
The multifaceted activities of ceragenins that make them a favorable candidate for further development of highly efficient formulations for oral hygiene and as therapeutics against oral diseases.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Li X., Liu Y., Yang X., Li C., Song Z. The Oral Microbiota: Community Composition, Influencing Factors, Pathogenesis, and Interventions. Front. Microbiol. 2022;13:895537. doi: 10.3389/fmicb.2022.895537. - DOI - PMC - PubMed
    1. Wade W.G. The oral microbiome in health and disease. Pharmacol. Res. 2013;69:137–143. doi: 10.1016/j.phrs.2012.11.006. - DOI - PubMed
    1. Palmer R.J. Composition and development of oral bacterial communities. Periodontol. 2000. 2014;64:20–39. doi: 10.1111/j.1600-0757.2012.00453.x. - DOI - PMC - PubMed
    1. Hayes R.B., Ahn J., Fan X., Peters B.A., Ma Y., Yang L., Agalliu I., Burk R.D., Ganly I., Purdue M.P., et al. Association of Oral Microbiome with Risk for Incident Head and Neck Squamous Cell Cancer. JAMA Oncol. 2018;4:358–365. doi: 10.1001/jamaoncol.2017.4777. - DOI - PMC - PubMed
    1. Rodríguez-Lozano B., González-Febles J., Garnier-Rodríguez J.L., Dadlani S., Bustabad-Reyes S., Sanz M., Sánchez-Alonso F., Sánchez-Piedra C., González-Dávila E., Díaz-González F. Association between severity of periodontitis and clinical activity in rheumatoid arthritis patients: A case-control study. Arthritis Res. Ther. 2019;21:27. doi: 10.1186/s13075-019-1808-z. - DOI - PMC - PubMed

LinkOut - more resources